Your challenge: Are you losing patients to non-adherence?
Pharmaceutical companies cannot afford to ignore the hidden value available by increasing patient adherence, but it's important to realize that patient adherence programs are not a 'one size fits all' approach.
Are you:
- measuring the effects of different patient adherence programs?
- developing programs for different patient groups or products?
- facing competitive programs in your market?
- competing internally for budget allocation for retention programs?
Our solution
Eularis 94.8 will uncover the underlying reasons for patient non-adherence and its financial impact on the brand's value and market share.
You’ll be able to:
- know which adherence programs for each brand are driving adherence and which are not
- measure the driver programs impact on adherence for each brand
- accurately assess the ROI of interventions
- implement the optimal solution